SCHEDULE: Masters Capital Management Discloses BrainsWay Ltd. Stake

Masters Capital Management, LLC and Michael Masters have filed an amendment to Schedule 13G, reporting beneficial ownership of 3.8% of BrainsWay Ltd. ordinary shares as of March 31, 2026.

Summary

• Masters Capital Management, LLC, an investment adviser, and Michael Masters have filed an amendment to Schedule 13G concerning their beneficial ownership of BrainsWay Ltd. ordinary shares.
• As of March 31, 2026, Masters Capital Management, LLC and Michael Masters collectively beneficially owned 1,500,000 ordinary shares of BrainsWay Ltd.
• This holding represents 3.8% of the total outstanding ordinary shares of BrainsWay Ltd., based on 39,165,806 shares outstanding as of December 31, 2025.
• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain new operational or financial information about BrainsWay Ltd.

Positives

• Masters Capital Management, LLC and Michael Masters maintain a significant stake (3.8%) in BrainsWay Ltd., indicating continued confidence or strategic interest.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a standard investment approach rather than a hostile takeover attempt.

Negatives

• The filing does not contain any negative financial results or operational challenges for BrainsWay Ltd.

Risks

• The filing does not explicitly mention any current issues or potential future challenges for BrainsWay Ltd.

Future Outlook

The filing does not contain any forward-looking statements or guidance from BrainsWay Ltd.

Management Comments

• The filing should not be construed as an admission that any of the reporting persons are, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors crossing certain ownership thresholds. This filing indicates Masters Capital Management's ongoing investment activity in the medical technology sector, where BrainsWay Ltd. operates.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant beneficial ownership, which can be a factor in market perception.

Next Steps

• Masters Capital Management, LLC and Michael Masters will continue to hold their beneficial ownership of BrainsWay Ltd. ordinary shares.

Key Dates

Keywords

BrainsWay Ltd., Schedule 13G, Masters Capital Management, Michael Masters, beneficial ownership, ordinary shares, SEC filing, investment adviser